Physician profile
Peter M Stasko
NPI 1245539923
$16,526.22
in general payments reported to CMS, 2019-2025
21 companies · $932 in 2025
The $932 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,366 · 2020: $3,677 · 2021: $5,802 · 2022: $206 · 2023: $834 · 2024: $709 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,474.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,658.59 | 2019-2025 | Arthrex |
| Prodigy Surgical Distribution, INC. | $4,840.43 | 2019-2021 | |
| Treace Medical Concepts, INC. | $540.40 | 2023-2025 | |
| Organogenesis INC. | $426.84 | 2019-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Integra Lifesciences Corporation | $302.62 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $294.30 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Renasys Touch, Q-Fix |
| Advanced Oxygen Therapy INC. | $283.89 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Bioventus LLC | $239.17 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $224.98 | 2019-2025 | A.L.P.S. |
| Medshape, INC. | $193.25 | 2024 | Dynanail Helix, Washer, 15 Mm |
| Celularity INC. | $125.00 | 2019 | |
| Paragon 28, INC. | $109.33 | 2025 | Portfolio |
| Kci USA, INC. | $85.89 | 2022 | |
| Amniox Medical, INC. | $57.83 | 2020 | |
| Horizon Therapeutics Plc | $34.26 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $25.82 | 2020 | |
| Depuy Synthes Sales INC. | $20.48 | 2022 | |
| Amgen INC. | $17.60 | 2024 | Krystexxa |
| Ethicon US, LLC | $17.28 | 2024 | Vistaseal |
| Biotissue Holdings INC. | $14.52 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.74 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Stasko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.